HER2 Targeted Molecular MR Imaging Using a De Novo Designed Protein Contrast Agent

The application of magnetic resonance imaging (MRI) to non-invasively assess disease biomarkers has been hampered by the lack of desired contrast agents with high relaxivity, targeting capability, and optimized pharmacokinetics. We have developed a novel MR imaging probe targeting to HER2, a biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Jingjuan, Li, Shunyi, Wei, Lixia, Jiang, Jie, Long, Robert, Mao, Hui, Wei, Ling, Wang, Liya, Yang, Hua, Grossniklaus, Hans E., Liu, Zhi-Ren, Yang, Jenny J.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063795/
https://www.ncbi.nlm.nih.gov/pubmed/21455310
http://dx.doi.org/10.1371/journal.pone.0018103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063795/
https://www.ncbi.nlm.nih.gov/pubmed/21455310
http://dx.doi.org/10.1371/journal.pone.0018103

Ejemplares similares